Long-lasting killer cells are present in our skin and act as a defence against intruders. Researchers from Denmark's University of Copenhagen and Sweden's Karolinska Institutet have now discovered how these cells are formed and demonstrated that higher concentrations of memory killer cells i
Specialised long-lasting killer cells are present in our skin and serve as a defence against invaders. Researchers from the University of Copenhagen in Denmark and the Karolinska Institutet in Sweden have now determined how these cells are created and demonstrated that higher concentrations
According to a new study, melanoma skin cancer cells fundamentally reorganise their internal power systems in order to move to other places of the body.
When the immune system's T cells are constantly stressed as a result of cancer or other chronic diseases, they suffer a process known as T cell fatigue. Our bodies cannot fight cancer without functioning T cells that attack tumour cells.
he immune system's T cells undergo a process known as T cell exhaustion when they are constantly stressed out as a result of cancer or other chronic disorders. Without functioning T cells, which destroy tumour cells, our bodies are unable to combat cancer. In order to increase the immune sys
A startling 89 per cent of desmoplastic melanoma patients in a nationwide clinical study responded to immunotherapy (pembrolizumab) alone, indicating that many patients could avoid the potential side effects of combination therapies and achieve disease control with this course of treatment.
Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer increased when a novel therapy prevented their egress from melanoma tumours.
New research indicates that simple laser treatments to the skin may help to prevent the development of basal cell carcinoma and squamous cell carcinoma, which are collectively known as keratinocyte carcinoma and are the most common types of cancer diagnosed in the United States
Cancer treatment has transformed thanks to immunotherapy. The five-year survival rate for advanced melanoma, the deadliest type of skin cancer, has climbed from less than 10% to more than 50% since the development of immunotherapy in 2011. Sadly, immunotherapy only works on about half of mel
Immunotherapy has changed cancer treatment. Since the introduction of immunotherapy in 2011, the five-year survival rate in advanced melanoma, the most lethal form of skin cancer, has increased from less than 10% to more than 50%. Unfortunately, only approximately half of melanoma patients r